Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019

In the past few years, we have seen several important advances in understanding of and therapy for endometrial cancer. This review highlights key recent abstracts and publications in endometrial cancer from 2015 to 2019. We focus on clinical trials in surgical staging and the utility of sentinel lym...

Descripción completa

Detalles Bibliográficos
Autores principales: Charo, Lindsey M., Plaxe, Steven C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567288/
https://www.ncbi.nlm.nih.gov/pubmed/31231511
http://dx.doi.org/10.12688/f1000research.17408.1
_version_ 1783427042485731328
author Charo, Lindsey M.
Plaxe, Steven C.
author_facet Charo, Lindsey M.
Plaxe, Steven C.
author_sort Charo, Lindsey M.
collection PubMed
description In the past few years, we have seen several important advances in understanding of and therapy for endometrial cancer. This review highlights key recent abstracts and publications in endometrial cancer from 2015 to 2019. We focus on clinical trials in surgical staging and the utility of sentinel lymph node mapping, adjuvant treatment for high-risk disease and HER2/neu-positive serous tumors, combination therapy for recurrent disease, molecular biology, and immunotherapy.
format Online
Article
Text
id pubmed-6567288
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-65672882019-06-20 Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019 Charo, Lindsey M. Plaxe, Steven C. F1000Res Review In the past few years, we have seen several important advances in understanding of and therapy for endometrial cancer. This review highlights key recent abstracts and publications in endometrial cancer from 2015 to 2019. We focus on clinical trials in surgical staging and the utility of sentinel lymph node mapping, adjuvant treatment for high-risk disease and HER2/neu-positive serous tumors, combination therapy for recurrent disease, molecular biology, and immunotherapy. F1000 Research Limited 2019-06-12 /pmc/articles/PMC6567288/ /pubmed/31231511 http://dx.doi.org/10.12688/f1000research.17408.1 Text en Copyright: © 2019 Charo LM and Plaxe SC http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Charo, Lindsey M.
Plaxe, Steven C.
Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019
title Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019
title_full Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019
title_fullStr Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019
title_full_unstemmed Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019
title_short Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019
title_sort recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567288/
https://www.ncbi.nlm.nih.gov/pubmed/31231511
http://dx.doi.org/10.12688/f1000research.17408.1
work_keys_str_mv AT charolindseym recentadvancesinendometrialcancerareviewofkeyclinicaltrialsfrom2015to2019
AT plaxestevenc recentadvancesinendometrialcancerareviewofkeyclinicaltrialsfrom2015to2019

Ejemplares similares